Viridian Therapeutics Dividends and Buybacks
Dividend criteria checks 0/6
Viridian Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-17.4%
Buyback Yield
Total Shareholder Yield | -17.4% |
Future Dividend Yield | 0% |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Sep 11Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way
Sep 10Viridian Therapeutics: Key Catalysts Coming In The Second Half Of The Year
Jun 12Is Viridian Therapeutics (NASDAQ:VRDN) Using Debt Sensibly?
May 28Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt
Sep 12Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?
May 15Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Apr 18Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?
Jan 08Viridian: Excellent Early Data, Strong Cash, Great Strategy, Large Market
Sep 09Viridian Therapeutics board compensation committee approves inducement grants
Sep 02An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued
Aug 22Viridian Therapeutics Q2 2022 Earnings Preview
Aug 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if VRDN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VRDN's dividend payments have been increasing.
Dividend Yield vs Market
Viridian Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (VRDN) | n/a |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.4% |
Industry Average (Biotechs) | 2.1% |
Analyst forecast (VRDN) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate VRDN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate VRDN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate VRDN's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as VRDN has not reported any payouts.